Which alpha-2 agonist is approved for horses and used as a sedative/analgesia, marketed under the name Dormosedan?

Study for the Veterinary Pharmacology Drugs Test. Prepare with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Which alpha-2 agonist is approved for horses and used as a sedative/analgesia, marketed under the name Dormosedan?

Explanation:
Detomidine is an alpha-2 adrenergic agonist that is approved for use in horses and marketed as Dormosedan for standing sedation and analgesia. It works by activating central alpha-2 receptors, which lowers norepinephrine release, producing reliable sedation with adjunct analgesia and smooth recovery. This makes it a go-to option for standing procedures or pre-anesthetic sedation in horses. Cardiovascular effects include some initial peripheral vasoconstriction with a reflex change in heart rate, followed by bradycardia and reduced cardiac output due to central sympathetic suppression. It can be reversed with an alpha-2 antagonist such as atipamezole if needed. The other options are not the Dormosedan product: romifidine is another equine alpha-2 agonist but not Dormosedan; pralidoxime is an organophosphate antidote, not a sedative; norepinephrine is a vasopressor, not an anesthetic/sedative.

Detomidine is an alpha-2 adrenergic agonist that is approved for use in horses and marketed as Dormosedan for standing sedation and analgesia. It works by activating central alpha-2 receptors, which lowers norepinephrine release, producing reliable sedation with adjunct analgesia and smooth recovery. This makes it a go-to option for standing procedures or pre-anesthetic sedation in horses. Cardiovascular effects include some initial peripheral vasoconstriction with a reflex change in heart rate, followed by bradycardia and reduced cardiac output due to central sympathetic suppression. It can be reversed with an alpha-2 antagonist such as atipamezole if needed. The other options are not the Dormosedan product: romifidine is another equine alpha-2 agonist but not Dormosedan; pralidoxime is an organophosphate antidote, not a sedative; norepinephrine is a vasopressor, not an anesthetic/sedative.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy